First Time Loading...

Applied Molecular Transport Inc.
NASDAQ:AMTI

Watchlist Manager
Applied Molecular Transport Inc. Logo
Applied Molecular Transport Inc.
NASDAQ:AMTI
Watchlist
Price: 0.263 USD Market Closed
Updated: Mar 28, 2024

Intrinsic Value

AMTI's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Applied Molecular Transport, Inc. is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment o... [ Read More ]

The intrinsic value of one AMTI stock under the Base Case scenario is 1.453 USD. Compared to the current market price of 0.263 USD, Applied Molecular Transport Inc. is Undervalued by 82%.

Key Points:
AMTI Intrinsic Value
Base Case
1.453 USD
Undervaluation 82%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Applied Molecular Transport Inc.

Backtest AMTI Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling AMTI stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Applied Molecular Transport Inc.'s business.

What risks and challenges
does Applied Molecular Transport Inc. face in the near future?

Summarize the latest earnings report
of Applied Molecular Transport Inc..

Provide P/E
for Applied Molecular Transport Inc. and its competitors.

Financials

Balance Sheet Decomposition
Applied Molecular Transport Inc.

Current Assets 18.8m
Cash & Short-Term Investments 18.1m
Other Current Assets 700k
Non-Current Assets 1.2m
PP&E 1.2m
Current Liabilities 3.8m
Accounts Payable 200k
Accrued Liabilities 3.6m
Efficiency

Earnings Waterfall
Applied Molecular Transport Inc.

Revenue
0 USD
Operating Expenses
-59.7m USD
Operating Income
-59.7m USD
Other Expenses
-15.1m USD
Net Income
-74.8m USD

Free Cash Flow Analysis
Applied Molecular Transport Inc.

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

AMTI Profitability Score
Profitability Due Diligence

Applied Molecular Transport Inc.'s profitability score is 27/100. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

Applied Molecular Transport Inc.'s profitability score is 27/100. The higher the profitability score, the more profitable the company is.

AMTI Solvency Score
Solvency Due Diligence

Applied Molecular Transport Inc.'s solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
49/100
Solvency
Score

Applied Molecular Transport Inc.'s solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AMTI Price Targets Summary
Applied Molecular Transport Inc.

Wall Street analysts forecast AMTI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMTI is 1 USD .

Lowest
Price Target
Not Available
Average
Price Target
1 USD
280% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

AMTI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

AMTI Price
Applied Molecular Transport Inc.

1M 1M
-
6M 6M
+55%
1Y 1Y
-25%
3Y 3Y
-99%
5Y 5Y
-99%
10Y 10Y
-99%
Annual Price Range
0.263
52w Low
0.1389
52w High
0.37
Price Metrics
Average Annual Return 9.26%
Standard Deviation of Annual Returns 91.83%
Max Drawdown -100%
Shares Statistics
Market Capitalization 10.8m USD
Shares Outstanding 41 849 000
Percentage of Shares Shorted 0.81%

AMTI Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Applied Molecular Transport Inc. Logo
Applied Molecular Transport Inc.

Country

United States of America

Industry

Biotechnology

Market Cap

10.8m USD

Dividend Yield

0%

Description

Applied Molecular Transport, Inc. is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment of autoimmune, inflammatory, and metabolic diseases. The company is headquartered in South San Francisco, California and currently employs 125 full-time employees. The company went IPO on 2020-06-05. The firm is leveraging its technology platform to design and develop a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The firm is building a portfolio of oral product candidates based on its technology platform, including AMT-101, an oral gastrointestinal (GI)-selective oral fusion of interleukin 10 (IL-10) that has completed a Phase 1b clinical trial in patients with ulcerative colitis (UC). The Company’s other product candidate, AMT-126, is a GI-selective oral fusion of interleukin 22 (IL-22). Its technology platform enables it to design and develop various oral biologic therapeutic modalities, such as peptides, proteins, full-length antibodies, antibody fragments, and ribonucleic acid (RNA) therapeutics with development-stage drugs.

Contact

CALIFORNIA
South San Francisco
450 East Jamie Court
+16503920420.0
https://www.appliedmt.com/company/

IPO

2020-06-05

Employees

125

Officers

Exec. Chairman
Mr. Graham K. Cooper
Co-Founder, CEO & Director
Dr. Tahir Mahmood Ph.D.
Pres & COO
Mr. Shawn M. Cross
Co-Founder & Director
Dr. Randall Mrsny Ph.D.
Chief Financial Officer
Mr. Brandon Hants
Chief Medical Officer
Dr. Bittoo Kanwar M.D.
Show More
Chief Technical Officer
Mr. Douglas A. Rich M.B.A, M.B.A.
Head of Investor Relations & Corp. Communications
Mr. Andrew H. Chang
Exec. VP & Gen. Counsel
Mr. Earl M. Douglas
Sr. VP of Research & Translational Science
Dr. Andy Whitney Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one AMTI stock?

The intrinsic value of one AMTI stock under the Base Case scenario is 1.453 USD.

Is AMTI stock undervalued or overvalued?

Compared to the current market price of 0.263 USD, Applied Molecular Transport Inc. is Undervalued by 82%.